Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.71 -4.25 (-0.84%)
At close: Oct 1, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) recorded Net Equity Issued and Repurchased of $3.11 million in Q2 2026, up 78.7% from $1.74 million a year earlier and up 33.6% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

On a TTM basis, Madrigal Pharmaceuticals' Net Equity Issued and Repurchased came in at $33.12 million as of Jun 30, 2026, down 12.0% year-over-year; for FY2025, it came in at $38.06 million, down 94.8% from FY2024.

  • Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of -31.3% (FY2021 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $735.06 million in FY2024 (+38.6%), $530.48 million in FY2023 (+100.7%), $264.34 million in FY2022 (+54.4%) and $171.24 million in FY2021.
  • Quarterly Net Equity Issued and Repurchased has ranged from $7,000 in Q3 2021 to $573.71 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased rose in three of the last eight quarters, with an average decline of 17.4%.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 378.9% in Q2 2024, against a decline of 98.7% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.33 million (Q1 2026), $9.94 million (Q4 2025) and $17.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Madrigal Pharmaceuticals 14.69 Bn 10.94 Bn - 3.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.11 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 9.94 Mn
Sep 30, 2025 17.74 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 8.64 Mn
Dec 31, 2024 19.77 Mn
Sep 30, 2024 7.46 Mn
Jun 30, 2024 134.12 Mn
Mar 31, 2024 573.71 Mn
Dec 31, 2023 479.92 Mn
Sep 30, 2023 4.66 Mn
Jun 30, 2023 28.01 Mn
Mar 31, 2023 17.90 Mn
Dec 31, 2022 264.34 Mn
Dec 31, 2021 170.75 Mn
Sep 30, 2021 7,000.00
Sep 30, 2018 451,000.00
Dec 31, 2017 -34.88 Mn
Sep 30, 2017 38.28 Mn
API Access

Madrigal Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MDGL&period=max&api_key=YOUR_API_KEY